Repligen: KeyBanc Capital Markets cut the target to $240 from $260. Maintains overweight rating.
https://www.marketscreener.com/quote/stock/REPLIGEN-CORPORATION-10664/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.